Company File · BSE 524516 · Latest filing Q2 FY27
Standalone = this company only. Consolidated = including its subsidiaries.
Bacil Pharma Ltd.
Data as of 19 Oct 2026 close · BSE · Latest results Q2 FY27
ISIN INE711D01018 · BACPHAR · Healthcare › Pharmaceuticals & Biotechnology
Price & valuation · BSE close, 19 Oct 2026
Usual 61.1×
Below its usual level
- P/E
- 25.4×
- Usual P/E
- 61.1×
- Price/book
- 1.16×
- Debt/equity
- 0.00×
- Promoter
- 0.00%
- Pledged
- 0.00%
Earnings callsNo earnings-call transcript from Bacil Pharma in our data yet. When it files one on BSE, the call notes appear here within a few hours. See its call page
Is it expensive, and is it a good business?
Key ratios
In short Priced below its own usual level (P/E 25.4× vs 61.1×) and has no debt.
What you pay Valuation
On standalone figures, buyers pay about ₹25 for every ₹1 the company earned per share over the last year. Below its 1-year median of 61.1×.
Uses standalone figures: the consolidated results we hold do not give four quarters of EPS (a quarter is missing or was filed without figures).
Latest BSE close ÷ last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 19th October 2026.
The share price is 1.2 times the accounting value of each share.
Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.
Needs four consecutive quarters.
Market value ÷ last 12 months' revenue. As of 19th October 2026.
Needs four consecutive quarters.
Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.
Earnings a year earlier were below ₹1 a share, too small to compare.
P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.
The company paid no dividend in the last 12 months.
Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.
How well it uses money Returns & strength
Needs four consecutive quarters.
Last 12 months' profit before interest & tax ÷ average (equity + borrowings).
Needs four consecutive quarters.
Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 30th September 2026.
Needs four consecutive quarters.
Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances).
Needs four consecutive quarters.
Last 12 months' revenue ÷ average total assets. As of 30th September 2026.
Needs four consecutive quarters.
Last 12 months' profit before interest & tax ÷ finance costs. As of 30th September 2026.
The company reported no borrowings.
Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 30th September 2026.
Who owns it Ownership & more
The founders or parent group own 0.00% of the company.
Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th September 2026.
Promoter holding did not change over the last quarter.
Latest quarter's promoter holding minus the previous quarter's. As of 30th September 2026.
Promoter holding, quarter by quarter
- Sep 20260.00%
- Jun 20260.00%
- Mar 20260.00%
- Dec 20250.08%
- Sep 20250.08%
Promoters reported no pledged shares.
Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th September 2026.
Pledged, quarter by quarter
- Sep 20260.00%
- Jun 20260.00%
- Mar 20260.00%
- Dec 20250.00%
- Sep 20250.00%
Needs a full-year cash-flow statement.
Cash from operations − spending on plant & equipment, latest full year.
Each share has a face (nominal) value of ₹10. It matters for dividends quoted as a percentage, not for valuation.
Face value per share as BSE lists it today.
About 1.44 crore shares were in issue.
BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. The latest results filing gives 1.40 crore. As of 19th October 2026.
Your ratios
Ratios you added. Your choices are remembered on this device.
The stock market values the company at about ₹29 crore.
Latest BSE close × BSE's count of listed shares. As of 19th October 2026.
Buying the whole business, including its debt and keeping its cash, would cost about ₹28 crore.
Market value + borrowings − cash & bank balances. As of 19th October 2026.
Needs four consecutive quarters.
Sum of the last four quarters' reported profit after tax. As of 30th September 2026.
Needs four consecutive quarters.
Sum of the last four quarters' basic EPS. Uses earnings per share from continuing operations, so a one-off gain from selling a business does not flatter it. As of 30th September 2026.
Each share is backed by about ₹18 of net assets on the books.
Shareholders' equity ÷ shares. As of 30th September 2026.
Needs four consecutive quarters.
EBITDA ÷ revenue over the last four quarters. As of 30th September 2026.
Not available from current filings.
Profit after tax ÷ revenue for the latest quarter. As of 30th September 2026.
Needs the same quarter from last year.
Latest quarter's revenue vs the same quarter last year. As of 30th September 2026.
Needs the same quarter from last year with a positive profit.
Latest quarter's profit after tax vs the same quarter last year (continuing operations when a one-off discontinued item exists). As of 30th September 2026.
No accepted balance sheet for this basis yet.
Current assets ÷ current liabilities. As of 30th September 2026.
Needs four consecutive quarters.
Trade receivables ÷ last 12 months' revenue × 365. As of 30th September 2026.
Needs four consecutive quarters.
Inventories ÷ last 12 months' revenue × 365. As of 30th September 2026.
Needs four consecutive quarters.
Other income ÷ profit before tax, last 12 months. As of 30th September 2026.
Needs a full-year cash-flow statement.
Latest full year's cash from operations ÷ profit after tax.
Cash exceeds borrowings by ₹1 crore.
Cash & bank balances − borrowings. As of 30th September 2026.
Needs reported tax expense that reconciles.
Tax expense ÷ profit before tax (continuing operations), last 12 months. As of 30th September 2026.
Needs four consecutive quarters.
Last 12 months' profit ÷ average total assets. As of 30th September 2026.
Needs four consecutive quarters.
Revenue − expenses + finance costs + depreciation, last four quarters. As of 30th September 2026.
Needs five financial years of cash flows.
Sum over five financial years of (cash from operations − capital expenditure).
Needs a full-year cash-flow statement.
Purchase of property, plant & equipment, latest full year.
No borrowings reported.
Current + non-current borrowings. As of 30th September 2026.
No verified shareholding pattern yet.
Foreign institutional holding from the latest shareholding pattern. As of 30th September 2026.
No verified shareholding pattern yet.
Domestic institutional holding (mutual funds, insurers, banks, pension funds). As of 30th September 2026.
The highest price in the last year was ₹61.8.
Highest intraday BSE price in the last 12 months (raw, not adjusted). As of 10th April 2026.
The lowest price in the last year was ₹10.65.
Lowest intraday BSE price in the last 12 months (raw, not adjusted). As of 26th August 2026.
The share price moved -50.4% over the last year.
Close today ÷ close a year ago − 1 (raw prices, dividends not included). As of 19th October 2026.
Needs positive 12-month EPS.
Dividends per share with an ex-date in the last 12 months ÷ the last four quarters' EPS. As of 30th September 2026.
Needs four financial years of results (three years of growth).
Compound annual growth in revenue over three financial years.
Needs four financial years of results (three years of growth).
Compound annual growth in profit after tax over three financial years.
Tap the i beside any ratio for a plain explanation.
How these are worked out
Price-based ratios use the latest BSE close (19th October 2026). Share count 1.44 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.
What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.
How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.
Who owns it: A steady promoter stake with nothing pledged is a calm sign.
+ Add your own ratios
Your choices are remembered on this device.
Last 1 quarters ₹ crore · Consolidated
| ₹ crore | Q2 FY27 |
|---|---|
| Revenue from operations | 0.0 |
| EBITDA | -0.1 |
| Operating margin | – |
| Profit after tax | 0.1 |
| Basic EPS (₹) | 0.06 |
Latest filings BSE
Corporate announcements 13
- 8 Oct 2026Resignation of Company Secretary / Compliance Officer
- 5 Oct 2026Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday, 14Th October, 2026
- 24 Sep 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAGM
Quarterly results 4
- 14 Oct 2026Un-Audited Financial Result For The Quarter And Half Yearly Ended 30Th September, 2026Financial Results
- 14 Oct 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th October, 2026
- 12 Aug 2026Un-Audited Financial Results For The Quarter Ended 30Th June, 2026
Conference calls 0
None in the filings we hold.
Investor presentations 0
None in the filings we hold.
Members see every filing, and what each means for the company in Corporate Intelligence.
The full Company File
- Price, P/E, P/B & returns charts
- Growth vs last year, explained
- Cash from operations vs profit
- Accounts checks
- Who owns it
- 8 quarters, balance sheet & cash flow
- Every BSE filing, in four panels
- Excel & CSV downloads
Education & analysis only, not investment advice or a recommendation.